This is a non-core endpoint: only basic statistics are computed.
Assault by drugs, medicaments and biological substances
VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
57 |
4. Check minimum number of eventsNone |
57 |
5. Include endpointsNone |
57 |
6. Filter based on genotype QC (FinnGen only) |
57 |
Control definitions (FinnGen only)
- Control exclude
- VWXY20_ASSAULT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X85-Y09
Similar endpoints
↥List of similar endpoints to
Assault by drugs, medicaments and biological substances
based on the number of shared cases.
Similar with more cases:
- Assault
- External causes of morbidity and mortality
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 57 | 29 | 28 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 41.11 | 41.96 | 40.24 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 55
- Matched controls
- 547
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X85.9
ICD-10 Finland
Assault by drugs, medicaments and biological substances by unknown person
+∞
45.1
37
*
T74.1
ICD-10 Finland
Physical abuse
+∞
17.6
16
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
39.9
14.0
17
6
X85.0
ICD-10 Finland
Assault by drugs, medicaments and biological substances by spouse or partner
+∞
11.9
11
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
12.8
10.0
18
20
Y09
ICD-10 Finland
Assault by unspecified means
+∞
9.6
9
*
N05AH04
ATC
quetiapine; oral
7.1
8.6
23
50
Y07
ICD-10 Finland
Other maltreatment
+∞
8.5
8
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
12.9
8.1
14
14
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.9
7.8
21
45
S06.0
ICD-10 Finland
Concussion
8.0
7.4
17
29
N05BA01
ATC
diazepam; systemic, rectal
6.8
6.6
17
34
N06AX11
ATC
mirtazapine; oral
4.5
6.5
29
108
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
+∞
6.4
6
*
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
+∞
6.4
6
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
17.5
6.1
9
6
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
17.5
6.1
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
21
7.72
8.11
2.9
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
23
6.34
6.32
3.7
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
6
17.43
6.13
1.0
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
30
5.32
5.63
2.9
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
31
142
3.59
5.36
5.2
4.9
inr
1.0
1.1
—
8
41
(3000764) Benzodiazepines [Presence] in Urine
13
34
4.66
4.85
2.9
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
34
4.66
4.85
2.9
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
34
4.66
4.85
2.9
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
35
4.52
4.67
2.9
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
91
3.31
4.30
3.8
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
15
48
3.88
4.30
2.0
2.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
14
7.40
4.17
3.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
35
200
2.94
3.79
5.4
3.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
21
93
2.99
3.58
5.9
4.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
33
189
2.77
3.46
7.6
6.8
mmol/l
1.2
1.2
2.21
26
164
(3044640) Blood type and Crossmatch panel - Blood
25
124
2.81
3.46
4.0
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
17
71
2.99
3.17
6.9
3.8
ng/l
483.2
87.5
—
8
43
(3026008) Bacteria identified in Urine by Culture
20
97
2.64
2.80
2.9
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
32
3.58
2.80
2.3
3.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
21
4.25
2.57
2.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
16
4.83
2.56
1.4
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
21
112
2.39
2.37
2.1
2.2
e6/l
0.4
0.2
0.31
15
89
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
13
5.02
2.33
1.2
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
62
2.67
2.30
3.6
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
50
2.77
2.20
2.2
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
21
117
2.26
2.12
2.1
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
58
2.61
2.09
1.1
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
16
4.06
1.99
1.8
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
28
179
2.11
1.99
2.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
121
2.16
1.93
2.3
1.9
—
—
—
0
0
(3019225) pH of Specimen
8
29
3.04
1.87
4.3
6.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
13
4.10
1.75
6.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
17
95
2.13
1.66
2.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
14
3.81
1.65
2.4
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
14
3.81
1.65
2.0
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
22
138
1.97
1.57
2.6
1.9
pmol/l
84.1
100.3
1.09
13
75
(3015736) pH of Urine
26
175
1.89
1.50
4.5
2.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
22
2.92
1.47
4.7
4.4
g/l
133.7
129.8
—
6
22
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
16
3.32
1.47
1.2
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
15
85
2.04
1.40
3.3
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
17
3.12
1.39
15.8
7.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
14
78
2.05
1.36
1.4
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
20
127
1.89
1.35
2.3
2.2
e6/l
8.7
11.2
0.41
15
105
(3018095) Leukocytes [#/volume] in Urine
23
153
1.84
1.35
2.7
2.7
e6/l
12.3
31.9
0.41
18
114
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
49
2.26
1.31
2.0
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
19
2.78
1.24
2.4
4.7
mmol/l
26.3
23.8
—
5
19
(3025941) Bacteria identified in Stool by Culture
6
26
2.46
1.22
2.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
39
313
1.78
1.16
5.4
3.5
—
—
—
0
0
(3012544) pH of Venous blood
7
31
2.43
1.15
4.4
3.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
18
116
1.81
1.15
4.5
3.1
%
91.6
94.9
0.22
18
116
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
21
142
1.76
1.14
2.5
2.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
22
152
1.73
1.11
4.4
2.8
ng/l
61.6
30.5
0.26
13
81
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
51
454
2.17
1.10
13.7
9.2
ml/min/173m2
95.5
90.9
1.17
42
367
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
109
1.80
1.10
1.7
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
109
1.80
1.10
8.5
7.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
47
2.08
1.08
2.2
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
9
47
2.08
1.08
3.2
7.0
mmol/l
1.0
1.0
—
9
42
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
47
2.08
1.08
2.4
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
77
1.89
1.06
3.2
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
52
466
2.32
1.01
19.9
11.5
%
41.7
41.6
0.05
37
390
(4035726)
7
37
2.01
0.98
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
19
133
1.64
0.89
2.3
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
22
160
1.61
0.89
10.3
5.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
179
1.59
0.87
4.3
2.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
6
31
2.04
0.87
2.0
3.7
kpa
6.1
5.4
—
6
31
(3000494) Fungus identified in Specimen by Culture
8
47
1.81
0.85
2.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
54
1.79
0.79
1.4
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
26
2.01
0.72
1.2
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
42
1.76
0.71
1.6
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
27
1.93
0.70
2.4
2.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
71
1.68
0.68
1.7
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
97
1.59
0.67
1.3
1.2
u/ml
1.2
3.3
—
5
41
(3019060) Gas panel - Arterial blood
5
29
1.79
0.65
13.2
7.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
50
1.70
0.65
2.3
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
21
168
1.40
0.50
6.9
3.6
u/l
34.3
30.8
0.42
21
161
(3021601) Nitrite [Presence] in Urine by Test strip
27
226
1.37
0.49
5.3
3.8
estimate
0.0
0.0
—
7
48
(3007164) IgA [Mass/volume] in Serum or Plasma
15
114
1.43
0.47
1.3
1.5
g/l
2.0
2.5
—
9
78
(3012516) Albumin [Mass/volume] in Urine
14
106
1.43
0.44
2.9
3.4
mg/l
4.7
57.1
—
7
76
(3035350) Ketones [Presence] in Urine by Test strip
27
229
1.34
0.44
4.4
2.7
estimate
0.0
0.0
—
7
49
(3009261) Glucose [Presence] in Urine by Test strip
27
230
1.33
0.43
4.4
2.7
estimate
0.0
0.0
—
7
45
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
3.2
—
1.5
—
0
16
(3050129) First trimester maternal screen panel - Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
35
1.47
0.40
1.4
2.1
—
—
—
0
0
(4010399)
5
35
1.47
0.40
1.4
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
6
41
1.52
0.37
5.3
2.8
—
0.6
—
0
11
(3029937) Albumin [Presence] in Urine by Test strip
15
119
1.35
0.36
6.1
2.8
estimate
0.0
0.0
—
7
48
(1761868) Lipid panel - Serum or Plasma
17
203
0.77
0.33
2.4
2.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
14
112
1.33
0.32
3.8
4.0
mg/mmol
1.2
7.3
—
7
77
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
37
400
0.79
0.30
3.1
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
37
1.38
0.24
3.4
2.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
5
37
1.38
0.24
6.2
2.9
—
0.2
—
0
9
(3025159) Blasts/100 leukocytes in Blood
5
38
1.35
0.24
2.8
2.8
—
0.1
—
0
7
(3002179) Metamyelocytes/100 leukocytes in Blood
5
39
1.31
0.23
6.2
2.7
—
0.4
—
0
7
(3013512) EKG study
12
99
1.27
0.22
3.3
2.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
11
0.00
0.21
0.0
1.4
—
6.8
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
11
0.00
0.21
0.0
3.5
—
55.1
—
0
11
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
11
0.00
0.21
0.0
3.3
—
3.5
—
0
11
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
2.4
—
0
7
(3044889) 12 lead EKG panel
34
315
1.20
0.21
4.6
3.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
55.4
—
0
13
(3036481) Cortisol [Moles/volume] in Serum or Plasma
6
51
1.20
0.20
1.7
2.2
nmol/l
332.5
399.5
—
6
45
(3002256) Pathology report gross observation
6
51
1.20
0.20
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
51
491
1.37
0.16
4.8
4.0
mmol/l
2.9
2.9
0.15
46
470
(3012095) Magnesium [Moles/volume] in Serum or Plasma
9
79
1.17
0.16
3.7
2.4
mmol/l
0.8
0.8
—
9
72
(3000492) Spirometry study
5
47
1.07
0.10
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
48
1.05
0.09
8.4
7.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
6
57
1.06
0.09
2.7
2.6
umol/l
10.6
14.6
—
6
52
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
61
0.80
0.09
1.0
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
6
73
0.80
0.08
4.0
2.1
ug/l
0.6
0.7
—
6
38
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
87
1.04
0.07
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
14
129
1.11
0.06
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
11
120
0.90
0.05
5.5
3.2
ug/l
1.3
1.5
0.25
11
110
(40760892) CBC W Ordered Manual Differential panel - Blood
12
130
0.90
0.05
1.9
4.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
45
458
0.92
0.03
26.4
13.4
g/l
333.1
333.8
0.17
45
458
(3011397) Hemoglobin [Presence] in Urine by Test strip
10
99
1.01
0.00
7.4
2.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
18.1
—
0
6
(4027681)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
32.7
—
0
6
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
6
0.00
0.00
0.0
1.7
—
77.1
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.2
—
18.6
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
80
1.00
0.00
1.1
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
1.8
—
0
7
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST – Assault by drugs, medicaments and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).